the Quarter ended March 31, 2018 To : Director and Manager Stock Exchange of Thailand Abico Holdings Public Company Limited would like explanation about the Company’s financial performance and operation
the year ended December 31, 2019 To Director and Manager the Stock Exchange of Thailand According to the Board of Directors’ Meeting No.2/ 2 0 2 0 of DOD Biotech Public Company Limited ( “ the Company
ABICO 009/KV/2017 May 11, 2017 Subject : Explanation on operation result for the Quarter ended March 31, 2017 To : Director and Manager Stock Exchange of Thailand Abico Holdings Public Company
Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial status which had changed over 20 percent
นาสูความเปนเลิศ ทั้งในดานพาณิชยและคุณภาพผลิตภัณฑอยางเปนมืออาชพี” August 15, 2017 Subject: Clarification on the cause of changes in operating results over 20 percent. To: Director and Manager The
Ref. No. 1711/056EN November 8, 2017 Subject Management Discussion and Analysis for Q3/2017 (Ending September 30, 2017) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public
) November 8, 2017 Re : Report the operating result for the year ended September 30 ,2017 by more than 20 percent. To : Director and Manager the Stock Exchange of Thailand Approved by the Board of Directors of
นาสูความเปนเลิศ ทั้งในดานพาณิชยและคุณภาพผลิตภัณฑอยางเปนมืออาชพี” November 14, 2017 Subject: Clarification on the cause of changes in operating results over 20 percent. To: Director and Manager
December 31, 2017) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial status for the year
Ref. No. 1802/008EN February 20, 2018 Subject Management Discussion and Analysis for the year 2017 (Ending December 31, 2017) (Additional) To Director and Manager of the Stock Exchange of Thailand